Quick Answer
Hepion Pharmaceuticals, Inc. reported Research And Development Expense of $445.5 thousand for the year ending 2025.
- Hepion Pharmaceuticals, Inc. showed a decrease of -96.2% in Research And Development Expense from 2024 to 2025.
- This data is from Hepion Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $122.4 thousand | Q3 2013: $13.6 thousand | Q4 2013: $9.2 thousand | Q1 2014: $72.5 thousand | Q3 2014: $384.1 thousand | Q4 2014: $1.82 million | Q1 2015: $2.61 million | Q3 2015: $3.77 million | Q4 2015: $4.04 million | Q1 2016: $3.19 million | Q3 2016: $3.13 million | Q4 2016: $4.32 million | Q1 2017: $2.94 million | Q2 2017: $3.26 million | Q3 2017: $3.96 million | Q1 2018: $2.26 million | Q2 2018: $2.12 million | Q3 2018: $2.17 million | Q1 2019: $518.0 thousand | Q2 2019: $755.7 thousand | Q3 2019: $846.5 thousand | Q1 2020: $2.64 million | Q2 2020: $2.95 million | Q3 2020: $3.78 million | Q1 2021: $3.50 million | Q2 2021: $4.19 million | Q3 2021: $5.80 million | Q1 2022: $4.31 million | Q2 2022: $15.70 million | Q3 2022: $5.74 million | Q1 2023: $9.80 million | Q2 2023: $11.88 million | Q3 2023: $8.52 million | Q1 2024: $2.54 million | Q2 2024: $7.14 million | Q3 2024: $2.76 million | Q1 2025: $22.2 thousand | Q2 2025: $423.3 thousand.
- Over the full 13 years of available data (2014 to 2025), Hepion Pharmaceuticals, Inc.'s Research And Development Expense has grown by 41.8%.
- Historical annual values: Fiscal year 2025: $445.5 thousand | Fiscal year 2024: $11.85 million | Fiscal year 2023: $35.64 million | Fiscal year 2022: $33.27 million | Fiscal year 2021: $20.40 million | Fiscal year 2020: $12.00 million | Fiscal year 2019: $3.18 million | Fiscal year 2018: $7.59 million | Fiscal year 2017: $13.37 million | Fiscal year 2017: $13.65 million | Fiscal year 2016: $15.02 million | Fiscal year 2015: $8.40 million | Fiscal year 2014: $314.2 thousand.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: